Navigation Links
Letrozole Beats Tamoxifen in Breast Cancer Therapy

Novartis' Femara (letrozole), one of a new class of breast cancer drugs, worked better than standard therapy with tamoxifen in treating breast cancer in women// with advanced disease. Femara is a member of a new class of drugs called aromatase inhibitors, which work differently to prevent certain kinds of breast cancer than does tamoxifen.

This new drug, Letrozole shrank tumors better and helped more women survive. The US Food and Drug Administration (FDA) approved Femara as first-line hormonal treatment for advanced breast cancer in postmenopausal women. At that time, an FDA advisory panel enthusiastically backed Femara based on Novartis' research comparing the drug with a generic version of tamoxifen, the gold standard treatment for advanced breast cancer.

Femara was initially approved by the FDA in 1997 as treatment for advanced, hormonally sensitive breast cancer that had not responded to other treatments. Novartis believes Femara may also have potential early in the course of breast cancer and is studying the drug as a pre-surgical therapy.
'"/>




Page: 1

Related medicine news :

1. New Study Confers All Clear Status On Letrozole, Infertility Drug
2. Nasal Spray Beats Antihistamine
3. Identifying Irregular Heart Beats
4. Stomach Beats Can Tell the Truth About Lying
5. Radiation Overdose at the Beatson Oncology Centre
6. Radio Therapy To Cure Irregular Heart Beats
7. For Super-Obese Patients, Duodenal Switch Beats Gastric Bypass
8. Dawn Machine Beats Wintertime Blues
9. Hypertension Treatment: US Beats Europe
10. Low-dose Aspirin Beats High-dose After Cardiac Surgery
11. Tamoxifen does not adversely affect the brain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... ... 05, 2016 , ... Every year 220 Mississippi kids are ... these children. The wishes provide hope and motivation through positive experiences while ... Mississippi, Brent Wilson said, “In 2016, the organization will grant 50% of wishes ...
(Date:5/5/2016)... ... ... A recent survey by the Midwest Business Group on Health (MBGH) ... the free preventive care benefits available to them as part of the Affordable Care ... and private employers, MBGH found that only 10% of large employers are aware of ...
(Date:5/5/2016)... ... 2016 , ... A local study examining asthma prevalence, severity ... of participating fifth-grade students already have or are at risk for developing asthma. ... the Division of Pulmonary, Allergy and Critical Care Medicine at Allegheny Health ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... ... Jennifer Drago presented a talk highlighting the organization’s successful Care Transitions ... Chicago. , The talk was titled “Minimizing Costs in the Post-Acute Environment Through ...
(Date:5/5/2016)... ... 05, 2016 , ... Talent Tech Labs (TTL) is pleased to ... National Nurses Week (May 6-12). Currently, HireNurses is a job listing and ... the Talent Tech Lab Virtual Incubation program, they will dramatically expand the functionality and ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 2016 Research and ... Acute Myeloid Leukemia Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... and Competitive Landscape Highlights 2016, provides comprehensive ... Acute Myeloid Leukemia epidemiology, Acute Myeloid Leukemia ...
(Date:5/3/2016)... Mo. , May 3, 2016 ... Medical Center,s Institute for Advancing Medical Innovation (IAMI) ... commercialize new drugs, diagnostics and medical devices. ... BioNovus Innovations with rights to license, develop and ... "This partnership represents a ...
(Date:5/3/2016)... 2016 ACME Markets, ... Delaware County Councilman Dave White ... all ACME pharmacies across Delaware ... and Prevention (CDC), naloxone has saved 26,463 lives nationwide over the ... Delaware County were authorized to administer naloxone to ...
Breaking Medicine Technology: